Stock 6472 BORA PHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Bora Pharmaceuticals Co., LTD.

Equities

6472

TW0006472004

Pharmaceuticals

End-of-day quote Taiwan S.E.
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
756 TWD -0.13% Intraday chart for Bora Pharmaceuticals Co., LTD. +3.42% +18.31%
Apr. 12 Bora Pharmaceuticals Co., LTD. agreed to acquire remaining 34.3% stake in Bora Biologics Co., Ltd. CI
Apr. 01 Bora Pharmaceuticals Co., LTD. completed the acquisition of Sawai America Holdings Inc. from Sawai Group Holdings Co., Ltd.. CI

Business Summary

Bora Pharmaceuticals Co Ltd is a Taiwan-based company principally engaged in the agency and sales of western medicines, as well as the research, development, manufacture and sales of new drugs and health products. The Company's main products are categorized into prescription drugs and health care products, including central nervous drugs, cardiovascular drugs, antibiotics, antiviral agents, ophthalmic drugs, gastrointestinal drugs, foam ingots and health care products. In addition, the Company has biopharmaceutical technologies related to the development of cell lines for the production of protein drugs, the development and analysis of upstream and downstream processes, as well as the establishment of quality control and testing specifications and the creation of cell banks.

Sales per Business

TWD in Million2022Weight2023Weight Delta
Sales
65.0 %
5,698 54.3 % 9,236 65.0 % +62.08%
Contract Development and Manufacturing Organization
34.9 %
4,788 45.6 % 4,951 34.9 % +3.41%
Other
0.1 %
8 0.1 % 13 0.1 % +58.73%

Sales per region

TWD in Million2022Weight2023Weight Delta
United States
77.2 %
6,514 62.1 % 10,955 77.2 % +68.17%
Europe
14.7 %
3,129 29.8 % 2,081 14.7 % -33.51%
Taiwan
7.4 %
851 8.1 % 1,053 7.4 % +23.81%
Other
0.8 %
-- 111 0.8 % -

Managers

Managers TitleAgeSince
Pao Hsi Sheng CEO
 Chief Executive Officer - 09-10-20
Chin Chu Wang DFI
 Director of Finance/CFO - 13-04-30
Raymond Lee CTO
 Chief Tech/Sci/R&D Officer - 18-06-24
Lynn Chuang HRO
 Human Resources Officer - 19-02-17

Members of the board

Members of the board TitleAgeSince
Shang Hung Shen BRD
 Director/Board Member 65 14-08-25
Kuan Pai Chen BRD
 Director/Board Member - 19-06-10
Pao Hsi Sheng CEO
 Chief Executive Officer - 09-10-20
Shih Min Chen BRD
 Director/Board Member - 13-03-31
Jui Yi Lin BRD
 Director/Board Member - 15-04-08
Ming Jung Lai BRD
 Director/Board Member - 17-06-19
Yi Chin Li BRD
 Director/Board Member - 17-06-19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 101,480,128 57,556,128 ( 56.72 %) 288,000 ( 0.2838 %) 56.72 %

Shareholders

NameEquities%Valuation
Pao Hsi Sheng
23.71 %
24,061,611 23.71 % 491 M NT$
Juipaohsing Investment Co. Ltd.
11.21 %
11,380,676 11.21 % 232 M NT$
TaYa Venture Capital Co. Ltd.
3.836 %
3,893,482 3.836 % 79 M NT$
Shih Min Chen
1.096 %
1,112,746 1.096 % 23 M NT$
Chin Chu Wang
0.2034 %
206,428 0.2034 % 4 M NT$
Capital Investment Trust Corp.
0.1165 %
118,283 0.1165 % 2 M NT$
First Securities Investment Trust Co. Ltd.
0.0596 %
60,527 0.0596 % 1 M NT$
Syd Fund Management A/S
0.0414 %
42,000 0.0414 % 856 969 NT$
Yuanta Securities Investment Trust Co., Ltd.
0.0395 %
40,069 0.0395 % 817 569 NT$
LähiTapiola Varainhoito Oy
0.0375 %
38,070 0.0375 % 776 781 NT$

Company contact information

Bora Pharmaceuticals Co., Ltd.

6th Floor, No. 2, Alley 36 Lane 26, Ruiguang Road

114 94, Taipei

+

http://www.bora-corp.com
address Bora Pharmaceuticals Co., LTD.(6472)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Bora Pharmaceuticals Co., LTD.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
756 TWD
Average target price
865 TWD
Spread / Average Target
+14.42%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
BORA PHARMACEUTICALS CO., LTD. Stock Bora Pharmaceuticals Co., LTD.
+18.31% 2.35B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.08% 653B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.67% 556B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.55% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.38% 331B
ABBVIE INC. Stock AbbVie Inc.
+3.82% 296B
ASTRAZENECA PLC Stock AstraZeneca PLC
+12.85% 233B
NOVARTIS AG Stock Novartis AG
+5.57% 201B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 193B
AMGEN INC. Stock Amgen Inc.
-6.32% 144B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 6472 Stock
  4. Company Bora Pharmaceuticals Co., LTD.